Psilocybin Could be Key to Helping Millions of People with Eating Disorders

With clinical trials supporting psychedelics, like psilocybin mushrooms for the treatment of obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, depression and anxiety, it’s only a matter of time before big pharmaceutical companies begin to invest heavily, and incorporate psychedelics into their own drug pipelines.

New Jersey Gov. Delays Signing of Legalization Bill

The New Jersey legalization bill has hit a snag as Democratic Gov. Phil Murphy wants changes to a decriminalization bill over a technical issue that shields minors from cannabis-related penalties, according to a Patch report. Murphy, a proponent of the reforms, wants to sign both the decriminalization and legalization bills simultaneously but wants cannabis possession penalties for minors to be like those of alcohol: legal for adults 21-and-older to possess and consume but illegal for those who are underage.

Nova Mentis Expands Psychedelic Drug Pipeline

VANCOUVER, BC, Dec. 29, 2020 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA" or the "Company") is pleased to announce that it has added two additional psychedelic compounds to its drug portfolio.